Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

6,776 total articles

ImmuCell Announces a 28.4% Increase in Product Sales in Q1 of 2026, based on Preliminary, Unaudited Sales Results

ImmuCell Announces a 28.4% Increase in Product Sales in Q1 of 2026, based on Preliminary, Unaudited Sales Results

ImmuCell Corporation announced preliminary, unaudited sales results for Q1 2026 showing a 28.4% increase in total product sales to $10.4 million compared to Q1 2025. Domestic sales rose significantly by 35.7%, driven primarily by Tri-Shield® First Defense® sales which grew 38.5%. International sales declined by 30.2%. The company attributes strong …

Vishay Intertechnology Announces 2026 Annual Meeting of Stockholders

Vishay Intertechnology Announces 2026 Annual Meeting of Stockholders

Vishay Intertechnology, Inc. announced its 2026 Annual Meeting of Stockholders will occur virtually on May 18, 2026, allowing stockholders to participate online. Proxy materials are available electronically and in paper format. The company highlights its broad semiconductor and passive component portfolio serving multiple technology sectors worldwi…

New Data from Week 52 of the Ongoing COACH Trial Showed that TransCon® hGH Accelerated TransCon® CNP’s Benefits Beyond Linear Growth in Children with Achondroplasia

New Data from Week 52 of the Ongoing COACH Trial Showed that TransCon® hGH Accelerated TransCon® CNP’s Benefits Beyond Linear Growth in Children with Achondroplasia

Ascendis Pharma announced new Week 52 data from its Phase 2 COACH trial demonstrating that combination therapy with once-weekly TransCon CNP and TransCon hGH significantly improved clinical measures beyond linear growth in children with achondroplasia, including arm span, spinal canal dimensions, and leg alignment. These results suggest enhanced th…

New Era Energy & Digital Announces Public Offering of Common Stock

New Era Energy & Digital Announces Public Offering of Common Stock

New Era Energy & Digital, Inc. has initiated an underwritten public offering of common stock on NASDAQ to raise proceeds primarily for repaying outstanding borrowings under a senior secured convertible promissory note and for general corporate purposes. The offering includes an option for underwriters to purchase additional shares and is subject to…

FDA Removes Partial Clinical Hold on MacroGenics’ LINNET Study

FDA Removes Partial Clinical Hold on MacroGenics’ LINNET Study

MacroGenics announced that the FDA has removed the partial clinical hold on its Phase 2 LINNET study investigating lorigerlimab, a bispecific antibody targeting PD-1 and CTLA-4, for gynecologic cancers. The company plans to resume enrollment under a revised protocol with enhanced safety measures and aims to provide a clinical update by mid-2026. To…

Cycurion Secures Multi-Year Contract Valued at Approximately $1 Million in First Year with Fortune 500 Company to Support Major Government Agency

Cycurion Secures Multi-Year Contract Valued at Approximately $1 Million in First Year with Fortune 500 Company to Support Major Government Agency

Cycurion, Inc., a provider of AI-driven cybersecurity solutions, announced a multi-year contract with a Fortune 500 company to support a major U.S. government agency. Valued at approximately $1 million in the first year, this partnership will deliver advanced AI cybersecurity services and application transition support over a minimum five-year term…

RenovoRx Secures First Notice of Allowance for Japanese Patent Covering its RenovoCath® Device for Targeted, Local Drug-Delivery via the Vasa Vasorum

RenovoRx Secures First Notice of Allowance for Japanese Patent Covering its RenovoCath® Device for Targeted, Local Drug-Delivery via the Vasa Vasorum

RenovoRx has obtained its first Notice of Allowance from the Japan Patent Office for a patent covering its RenovoCath device. This strengthens the company's global intellectual property around its unique targeted drug-delivery technology and supports expansion into the Japanese market. RenovoCath is an FDA-cleared catheter system designed to delive…

Scorpio Tankers Inc. Announces Pricing of Convertible Senior Notes due 2031 and Concurrent Stock Repurchase

Scorpio Tankers Inc. Announces Pricing of Convertible Senior Notes due 2031 and Concurrent Stock Repurchase

Scorpio Tankers Inc. announced a $325 million offering of 1.75% convertible senior notes due 2031, with an option to increase by $50 million. Concurrently, the company plans to repurchase approximately 1.34 million shares of common stock for about $100 million. Net proceeds will be used for the share repurchase and general corporate purposes, suppo…

Mawson Infrastructure Group Announces Reconstitution of its Board and New Executive Leadership to Drive Transformation

Mawson Infrastructure Group Announces Reconstitution of its Board and New Executive Leadership to Drive Transformation

Mawson Infrastructure Group has reconstituted its Board of Directors with seven new members and appointed new executive leadership including Joshua Kilgore as Executive Chairman and Phil Stanley as CEO. This governance overhaul aims to stabilize the company's capital structure, evaluate operations strategically, and expand its asset base to capital…

Perma-Fix to Present at Gabelli Funds’ 12th Annual Waste & Environmental Services Symposium in New York City on April 9th

Perma-Fix to Present at Gabelli Funds’ 12th Annual Waste & Environmental Services Symposium in New York City on April 9th

Perma-Fix Environmental Services, Inc. announced that its CEO and CFO will present at the Gabelli Funds' 12th Annual Waste & Environmental Services Symposium in New York City. The event will focus on waste and environmental service industry trends, sustainability investing, and business fundamentals. The company offers nuclear and mixed waste manag…

Spectral AI Names David McGuire, CPA, as Chief Financial Officer

Spectral AI Names David McGuire, CPA, as Chief Financial Officer

Spectral AI, Nasdaq-listed AI healthcare company specializing in wound care diagnostics, announced David McGuire as its new CFO effective May 4, 2026. McGuire brings over 20 years of finance and accounting experience including roles at publicly traded companies, enhancing Spectral AI's financial governance as it nears commercialization of its DeepV…

Aclaris Therapeutics to Participate in the H.C. Wainwright 4th Annual Inflammatory Skin Disease Virtual Conference

Aclaris Therapeutics to Participate in the H.C. Wainwright 4th Annual Inflammatory Skin Disease Virtual Conference

Aclaris Therapeutics, a clinical-stage biopharmaceutical company specializing in immuno-inflammatory diseases, announced participation of its CEO and senior leadership in a fireside chat at the H.C. Wainwright 4th Annual Inflammatory Skin Disease Virtual Conference on April 14, 2026. The event will be webcast live and archived on the company's webs…

Equillium Announces Poster Presentations at IMMUNOLOGY2026™, the Annual Meeting of the American Association of Immunologists

Equillium Announces Poster Presentations at IMMUNOLOGY2026™, the Annual Meeting of the American Association of Immunologists

Equillium, Inc. announced that new preclinical data for its investigational therapy EQ504 will be presented as posters at IMMUNOLOGY2026, highlighting EQ504's potential as a potent AhR modulator with multi-modal, non-immunosuppressive actions aimed at treating autoimmune and inflammatory disorders such as ulcerative colitis and inflammatory lung di…

Vornado Releases 2025 Sustainability Report

Vornado Releases 2025 Sustainability Report

Vornado Realty Trust released its 17th annual Sustainability Report, showcasing major accomplishments in environmental performance including 100% LEED and WELL certifications across its portfolio, a significant reduction in energy consumption, and top rankings in sustainability benchmarks like GRESB. The company continues to procure 100% renewable …